ITCI
NASDAQIntra-Cellular Therapies Inc · Healthcare · Drug Manufacturers - Specialty & Generic
—
Loading quote…
Highlights
Market Cap
$14.05B
PE Ratio
—
EV to Ebitda
—
Earnings Yield
-0.56%
Revenue (TTM)
$680.5M
Net Income (TTM)
$-74.7M
Revenue (Annual YoY Growth)
47.24%
Revenue (Quarterly YoY Growth)
51.49%
Profit Margin
-10.97%
Return on Equity
-8.07%
Debt to Equity Ratio
0
Dividend Yield
0.00%
All fundamentals
Core10 fields›
Market Cap$14.05B
Revenue TTM$680.5M
Shares Outstanding106.3M
Float94223125
Float Short2.22%
Days To Cover1.1928
Short Interest2334807.0
Insider Ownership2.08%
Relative Strength99.3
GARP3942
Growth Estimates5 fields›
Revenue Growth (Annual)47.24%
Revenue Growth (Quarterly YoY)51.49%
Operating Revenue Growth (Annual)0.472388
Operating Revenue Growth (Quarterly YoY)0.514935
3-Year Revenue Growth102.70%
Operations27 fields›
Revenue TTM$680.5M
Gross Margin TTM91.63%
Gross Margin (Quarterly)89.76%
R&D % of Revenue TTM34.70%
R&D Expenses TTM$236.1M
Operating Margin TTM-17.15%
Operating Margin (Quarterly)-14.66%
Operating Expenses TTM$740.3M
Profit Margin TTM-10.97%
Profit Margin (Quarterly)-8.48%
Net Income TTM$-74.7M
EPS TTM-0.73
EPS (Quarterly)-0.16
EBIT Margin TTM-17.15%
EBIT Margin (Quarterly)-14.66%
EBITDA Margin TTM-17.08%
EBITDA Margin (Quarterly)-14.60%
EBITDA TTM$-116.2M
CFO % of Revenue TTM-10.75%
CFO % of Revenue (Quarterly)-6.56%
CFO TTM$-73.2M
Cash Margin-10.83%
Capital Expenditures$0.32M
FCF % of Revenue TTM-10.80%
FCF % of Revenue (Quarterly)-6.35%
FCF TTM$-73.5M
Fundamental Score3
Efficiency6 fields›
ROE-8.07%
ROA-6.80%
ROIC-8.07%
CROCI-7.94%
Stock Comp % (Quarterly)8.20%
Stock Comp % TTM9.41%
Valuation14 fields›
P/E Forward1045.3966
P/S Forward14.6864
EV/EBITDA Forward-1022.7488
EV/Revenues (TTM)19.0382
EV/Revenues Forward13.633
EV/CFO-107.5761
EV/FCF (TTM)-176.2683
Price To Book12.1525
Price to Tangible Book6.8868
Earnings Yield-0.56%
FCF Yield-0.54%
Dividend Yield0.00%
Payout Ratio0.00%
Value Score1
Relative to Industry5 fields›
Relative Gross Margin (Quarterly)1.6082
Relative P/S9.7194
Relative P/B6.3991
Relative Dividend Yield0
Relative Debt to Equity0
Liquidity10 fields›
Cash Per Share9.4227
Current Ratio6.3556
Cash & ST Assets$1.00B
Total Debt$0.00M
Total Assets$1.37B
Total Liabilities$218.5M
Shareholders Equity$1.15B
Debt to Equity0
Debt to Assets0.00%
Debt to EBITDA (TTM)0
Yields3 fields›
Dividend Yield0.00%
Payout Ratio0.00%
Earnings Yield-0.56%
Options Flow8 fields›
Call Volume0
Put Volume0
Put/Call Ratio0
Call $ Volume0
Put $ Volume0
Put/Call $ Ratio0
Call OI30248
Put OI27133
News AI summary
Past 90 days of news, summarised by GPT
Click Generate to run a GPT analysis. Cached for 24h once generated.
Press release AI summary
Past 90 days of press releases, summarised by GPT
Click Generate to run a GPT analysis. Cached for 24h once generated.
Income statement AI analysis
Recent quarterly income statements with margin trends
Click Generate to run a GPT analysis. Cached for 24h once generated.
Balance sheet AI analysis
Recent quarterly balance sheets with leverage trends
Click Generate to run a GPT analysis. Cached for 24h once generated.
Cash flow AI analysis
Recent quarterly cash flow statements with FCF trends
Click Generate to run a GPT analysis. Cached for 24h once generated.